NEAAV
Live / Applied — Fourth extension granted (statement of use) (as of 20 Mar 2026)
What this means for you
Not registered yet, but its 09 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97927507
- Mark type
- Stylized text
- Filed
- 09 May 2023
- Published for opposition
- 12 Mar 2024
- Attorney of record
- Kristen Mollnow Walsh
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; DNA based vaccines; DNA extracts, namely, nucleic acid sequences and chemical reagents for medical use; Therapeutic DNA, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes; Biotechnological products, namely, viral DNA vectors, DNA vectors, and rAAV vectors, for the delivery of genes and other materials, in the nature of DNA, RNA, and transcriptional targeting promoters, to a biological cell for medical purposes; Biological preparations, namely, viral vectors, rAAV vectors, and DNA extracts for production of DNA vectors and viral vectors for medical purposes
Owner
- Asklepios BioPharmaceutical, Inc., Research Triangle Park, NC, US
- Asklepios BioPharmaceutical, Inc., Research Triangle Park, NC, US
Prosecution history
- 21 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Mar 2026 — SOU EXTENSION 4 GRANTED
- 20 Mar 2026 — SOU EXTENSION 4 FILED
- 19 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 13 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Mar 2026 — SOU EXTENSION 3 GRANTED
- 10 Oct 2025 — SOU EXTENSION 3 FILED
- 12 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 08 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 May 2025 — SOU EXTENSION 2 GRANTED
- 07 May 2025 — SOU EXTENSION 2 FILED
- 07 May 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Nov 2024 — SOU EXTENSION 1 GRANTED